25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Cambium Bio Limited
Buy, Hold or Sell?

Let's analyze Cambium Bio Limited together

I guess you are interested in Cambium Bio Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cambium Bio Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Cambium Bio Limited

I send you an email if I find something interesting about Cambium Bio Limited.

1. Quick Overview

1.1. Quick analysis of Cambium Bio Limited (30 sec.)










1.2. What can you expect buying and holding a share of Cambium Bio Limited? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.01
Expected worth in 1 year
A$0.07
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$0.06
Return On Investment
9.8%

For what price can you sell your share?

Current Price per Share
A$0.61
Expected price per share
A$0.6 - A$0.6
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cambium Bio Limited (5 min.)




Live pricePrice per Share (EOD)
A$0.61
Intrinsic Value Per Share
A$-0.14 - A$0.08
Total Value Per Share
A$-0.14 - A$0.08

2.2. Growth of Cambium Bio Limited (5 min.)




Is Cambium Bio Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$1.8m-$1.1m$2.9m165.4%

How much money is Cambium Bio Limited making?

Current yearPrevious yearGrowGrow %
Making money-$1.4m-$1m-$370k-25.2%
Net Profit Margin-313,736.4%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Cambium Bio Limited (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cambium Bio Limited?

Welcome investor! Cambium Bio Limited's management wants to use your money to grow the business. In return you get a share of Cambium Bio Limited.

First you should know what it really means to hold a share of Cambium Bio Limited. And how you can make/lose money.

Speculation

The Price per Share of Cambium Bio Limited is A$0.61. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cambium Bio Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cambium Bio Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.01. Based on the TTM, the Book Value Change Per Share is A$0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cambium Bio Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-0.8%0.00-0.8%0.00-0.6%0.00-0.5%-0.01-0.9%
Usd Book Value Change Per Share0.011.6%0.011.6%-0.01-1.0%0.000.6%0.00-0.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.011.6%0.011.6%-0.01-1.0%0.000.6%0.00-0.2%
Usd Price Per Share0.00-0.00-0.00-0.03-0.05-
Price to Earnings Ratio-0.68--0.68--1.27--3.63--3.60-
Price-to-Total Gains Ratio0.33-0.33--0.74-0.45--125.94-
Price to Book Ratio0.55-0.55--1.18--28.31--11.57-
Price-to-Total Gains Ratio0.33-0.33--0.74-0.45--125.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.396805
Number of shares2520
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.00
Gains per Quarter (2520 shares)24.569.80
Gains per Year (2520 shares)98.2439.21
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10988803929
2019618607868
302952840118107
403933820157146
504914800196185
605895780235224
706886760274263
807867740314302
908848720353341
1009829700392380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%2.08.00.020.0%5.010.02.029.4%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%3.02.00.060.0%4.06.00.040.0%8.09.00.047.1%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%4.00.013.023.5%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%3.02.00.060.0%4.06.00.040.0%8.09.00.047.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Cambium Bio Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0150.0150%-0.009+163%0.006+151%-0.002+112%
Book Value Per Share--0.0090.0090%-0.006+165%0.004+129%0.008+17%
Current Ratio--1.3311.3310%0.282+372%1.658-20%2.951-55%
Debt To Asset Ratio--0.5090.5090%3.540-86%1.236-59%1.055-52%
Debt To Equity Ratio--1.0351.0350%-+100%0.693+49%0.470+120%
Dividend Per Share----0%-0%-0%-0%
Eps---0.007-0.0070%-0.006-25%-0.004-42%-0.008+9%
Free Cash Flow Per Share---0.001-0.0010%-0.002+324%-0.003+505%-0.004+670%
Free Cash Flow To Equity Per Share--0.0100.0100%0.001+1064%0.001+557%0.002+416%
Gross Profit Margin--1.0001.0000%1.412-29%1.059-6%1.058-5%
Intrinsic Value_10Y_max--0.075--------
Intrinsic Value_10Y_min---0.145--------
Intrinsic Value_1Y_max---0.001--------
Intrinsic Value_1Y_min---0.008--------
Intrinsic Value_3Y_max--0.004--------
Intrinsic Value_3Y_min---0.030--------
Intrinsic Value_5Y_max--0.016--------
Intrinsic Value_5Y_min---0.058--------
Market Cap186926565.120+99%1532184.9601532184.9600%2145058.944-29%13299365.453-88%24472058.181-94%
Net Profit Margin---3137.364-3137.3640%--100%-627.873-80%-338.673-89%
Operating Margin----0%-0%-0.0470%-25.3030%
Operating Ratio----0%-0%0.730-100%32.264-100%
Pb Ratio67.329+99%0.5520.5520%-1.182+314%-28.312+5230%-11.574+2197%
Pe Ratio-82.866-12100%-0.679-0.6790%-1.272+87%-3.627+434%-3.604+431%
Price Per Share0.610+99%0.0050.0050%0.007-29%0.043-88%0.080-94%
Price To Free Cash Flow Ratio-1199.293-12100%-9.830-9.8300%-3.248-67%-3.799-61%-25.528+160%
Price To Total Gains Ratio40.713+99%0.3340.3340%-0.742+322%0.447-25%-125.935+37837%
Quick Ratio--0.1070.1070%0.271-61%1.526-93%1.821-94%
Return On Assets---0.399-0.3990%-2.361+491%-1.060+165%-0.954+139%
Return On Equity---0.812-0.8120%--100%-0.874+8%-0.729-10%
Total Gains Per Share--0.0150.0150%-0.009+163%0.006+151%-0.002+112%
Usd Book Value--1806003.3161806003.3160%-1180630.179+165%787191.777+129%1544463.871+17%
Usd Book Value Change Per Share--0.0100.0100%-0.006+163%0.004+151%-0.001+112%
Usd Book Value Per Share--0.0060.0060%-0.004+165%0.003+129%0.005+17%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.005-0.0050%-0.004-25%-0.003-42%-0.005+9%
Usd Free Cash Flow---101389.532-101389.5320%-429631.832+324%-613349.945+505%-780736.800+670%
Usd Free Cash Flow Per Share--0.0000.0000%-0.001+324%-0.002+505%-0.003+670%
Usd Free Cash Flow To Equity Per Share--0.0060.0060%0.001+1064%0.001+557%0.001+416%
Usd Market Cap121595730.611+99%996686.316996686.3160%1395360.843-29%8651237.227-88%15919073.847-94%
Usd Price Per Share0.397+99%0.0030.0030%0.005-29%0.028-88%0.052-94%
Usd Profit---1467375.133-1467375.1330%-1097317.392-25%-1302086.595-11%-1812070.139+23%
Usd Revenue--467.710467.7100%-+100%1135914.809-100%1429893.453-100%
Usd Total Gains Per Share--0.0100.0100%-0.006+163%0.004+151%-0.001+112%
 EOD+6 -2MRQTTM+0 -0YOY+19 -135Y+18 -1510Y+20 -13

3.3 Fundamental Score

Let's check the fundamental score of Cambium Bio Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-82.866
Price to Book Ratio (EOD)Between0-167.329
Net Profit Margin (MRQ)Greater than0-3,137.364
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.107
Current Ratio (MRQ)Greater than11.331
Debt to Asset Ratio (MRQ)Less than10.509
Debt to Equity Ratio (MRQ)Less than11.035
Return on Equity (MRQ)Greater than0.15-0.812
Return on Assets (MRQ)Greater than0.05-0.399
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Cambium Bio Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5090.038
Ma 20Greater thanMa 500.456
Ma 50Greater thanMa 1000.427
Ma 100Greater thanMa 2000.397
OpenGreater thanClose0.595
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Cambium Bio Limited

Regeneus Ltd, a clinical stage regenerative medicine company, develops cell-based therapies for the human health markets with a focus on osteoarthritis and other musculoskeletal disorders, neuropathic pain, and dermatology diseases in Australia. The company's platform technology includes Progenza, a multi-synergistic therapy, which has completed Phase I clinical trial for the treatment of osteoarthritis; and in pre-clinical stage to treat neuropathic pain. It also develops Sygenus that is in pre-clinical stage for the treatment of skin wound healing. The company was incorporated in 2007 and is headquartered in Paddington, Australia.

Fundamental data was last updated by Penke on 2024-11-14 22:53:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Cambium Bio Limited earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cambium Bio Limited to the Biotechnology industry mean.
  • A Net Profit Margin of -313,736.4% means that $-3,137.36 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cambium Bio Limited:

  • The MRQ is -313,736.4%. The company is making a huge loss. -2
  • The TTM is -313,736.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-313,736.4%TTM-313,736.4%0.0%
TTM-313,736.4%YOY--313,736.4%
TTM-313,736.4%5Y-62,787.3%-250,949.1%
5Y-62,787.3%10Y-33,867.3%-28,920.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-313,736.4%-115.9%-313,620.5%
TTM-313,736.4%-210.8%-313,525.6%
YOY--214.5%+214.5%
5Y-62,787.3%-342.2%-62,445.1%
10Y-33,867.3%-464.5%-33,402.8%
4.3.1.2. Return on Assets

Shows how efficient Cambium Bio Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cambium Bio Limited to the Biotechnology industry mean.
  • -39.9% Return on Assets means that Cambium Bio Limited generated $-0.40 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cambium Bio Limited:

  • The MRQ is -39.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -39.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-39.9%TTM-39.9%0.0%
TTM-39.9%YOY-236.1%+196.2%
TTM-39.9%5Y-106.0%+66.0%
5Y-106.0%10Y-95.4%-10.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-39.9%-11.1%-28.8%
TTM-39.9%-11.7%-28.2%
YOY-236.1%-11.3%-224.8%
5Y-106.0%-12.7%-93.3%
10Y-95.4%-14.3%-81.1%
4.3.1.3. Return on Equity

Shows how efficient Cambium Bio Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cambium Bio Limited to the Biotechnology industry mean.
  • -81.2% Return on Equity means Cambium Bio Limited generated $-0.81 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cambium Bio Limited:

  • The MRQ is -81.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -81.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-81.2%TTM-81.2%0.0%
TTM-81.2%YOY--81.2%
TTM-81.2%5Y-87.4%+6.2%
5Y-87.4%10Y-72.9%-14.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-81.2%-14.2%-67.0%
TTM-81.2%-15.8%-65.4%
YOY--13.9%+13.9%
5Y-87.4%-18.5%-68.9%
10Y-72.9%-19.5%-53.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Cambium Bio Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Cambium Bio Limited is operating .

  • Measures how much profit Cambium Bio Limited makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cambium Bio Limited to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cambium Bio Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-4.7%+4.7%
5Y-4.7%10Y-2,530.3%+2,525.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--258.6%+258.6%
TTM--318.3%+318.3%
YOY--224.0%+224.0%
5Y-4.7%-386.5%+381.8%
10Y-2,530.3%-497.6%-2,032.7%
4.3.2.2. Operating Ratio

Measures how efficient Cambium Bio Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cambium Bio Limited:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.730-0.730
5Y0.73010Y32.264-31.534
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.594-2.594
TTM-3.360-3.360
YOY-3.299-3.299
5Y0.7304.788-4.058
10Y32.2646.528+25.736
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Cambium Bio Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cambium Bio Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.33 means the company has $1.33 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cambium Bio Limited:

  • The MRQ is 1.331. The company is just able to pay all its short-term debts.
  • The TTM is 1.331. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.331TTM1.3310.000
TTM1.331YOY0.282+1.048
TTM1.3315Y1.658-0.328
5Y1.65810Y2.951-1.292
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3313.658-2.327
TTM1.3313.874-2.543
YOY0.2824.672-4.390
5Y1.6585.960-4.302
10Y2.9516.277-3.326
4.4.3.2. Quick Ratio

Measures if Cambium Bio Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cambium Bio Limited to the Biotechnology industry mean.
  • A Quick Ratio of 0.11 means the company can pay off $0.11 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cambium Bio Limited:

  • The MRQ is 0.107. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.107. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.107TTM0.1070.000
TTM0.107YOY0.271-0.164
TTM0.1075Y1.526-1.419
5Y1.52610Y1.821-0.295
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1073.104-2.997
TTM0.1073.426-3.319
YOY0.2714.498-4.227
5Y1.5265.933-4.407
10Y1.8216.426-4.605
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Cambium Bio Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Cambium Bio Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cambium Bio Limited to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.51 means that Cambium Bio Limited assets are financed with 50.9% credit (debt) and the remaining percentage (100% - 50.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cambium Bio Limited:

  • The MRQ is 0.509. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.509. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.509TTM0.5090.000
TTM0.509YOY3.540-3.032
TTM0.5095Y1.236-0.727
5Y1.23610Y1.055+0.181
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5090.354+0.155
TTM0.5090.345+0.164
YOY3.5400.311+3.229
5Y1.2360.366+0.870
10Y1.0550.382+0.673
4.5.4.2. Debt to Equity Ratio

Measures if Cambium Bio Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cambium Bio Limited to the Biotechnology industry mean.
  • A Debt to Equity ratio of 103.5% means that company has $1.03 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cambium Bio Limited:

  • The MRQ is 1.035. The company is able to pay all its debts with equity. +1
  • The TTM is 1.035. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.035TTM1.0350.000
TTM1.035YOY-+1.035
TTM1.0355Y0.693+0.342
5Y0.69310Y0.470+0.223
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0350.398+0.637
TTM1.0350.437+0.598
YOY-0.378-0.378
5Y0.6930.452+0.241
10Y0.4700.495-0.025
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cambium Bio Limited generates.

  • Above 15 is considered overpriced but always compare Cambium Bio Limited to the Biotechnology industry mean.
  • A PE ratio of -0.68 means the investor is paying $-0.68 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cambium Bio Limited:

  • The EOD is -82.866. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.679. Based on the earnings, the company is expensive. -2
  • The TTM is -0.679. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-82.866MRQ-0.679-82.187
MRQ-0.679TTM-0.6790.000
TTM-0.679YOY-1.272+0.592
TTM-0.6795Y-3.627+2.948
5Y-3.62710Y-3.604-0.023
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-82.866-2.160-80.706
MRQ-0.679-2.428+1.749
TTM-0.679-3.145+2.466
YOY-1.272-3.304+2.032
5Y-3.627-6.080+2.453
10Y-3.604-6.625+3.021
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cambium Bio Limited:

  • The EOD is -1,199.293. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.830. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -9.830. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1,199.293MRQ-9.830-1,189.462
MRQ-9.830TTM-9.8300.000
TTM-9.830YOY-3.248-6.582
TTM-9.8305Y-3.799-6.032
5Y-3.79910Y-25.528+21.729
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1,199.293-2.980-1,196.313
MRQ-9.830-3.295-6.535
TTM-9.830-3.682-6.148
YOY-3.248-4.523+1.275
5Y-3.799-8.162+4.363
10Y-25.528-9.239-16.289
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Cambium Bio Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.55 means the investor is paying $0.55 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cambium Bio Limited:

  • The EOD is 67.329. Based on the equity, the company is expensive. -2
  • The MRQ is 0.552. Based on the equity, the company is cheap. +2
  • The TTM is 0.552. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD67.329MRQ0.552+66.777
MRQ0.552TTM0.5520.000
TTM0.552YOY-1.182+1.734
TTM0.5525Y-28.312+28.864
5Y-28.31210Y-11.574-16.738
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD67.3291.869+65.460
MRQ0.5522.027-1.475
TTM0.5522.365-1.813
YOY-1.1822.419-3.601
5Y-28.3123.668-31.980
10Y-11.5744.362-15.936
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cambium Bio Limited.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets5,649
Total Liabilities2,873
Total Stockholder Equity2,776
 As reported
Total Liabilities 2,873
Total Stockholder Equity+ 2,776
Total Assets = 5,649

Assets

Total Assets5,649
Total Current Assets3,200
Long-term Assets2,449
Total Current Assets
Cash And Cash Equivalents 2,865
Net Receivables 257
Total Current Assets  (as reported)3,200
Total Current Assets  (calculated)3,122
+/- 78
Long-term Assets
Intangible Assets 2,449
Long-term Assets Other 0
Long-term Assets  (as reported)2,449
Long-term Assets  (calculated)2,449
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,405
Long-term Liabilities468
Total Stockholder Equity2,776
Total Current Liabilities
Accounts payable 1,221
Total Current Liabilities  (as reported)2,405
Total Current Liabilities  (calculated)1,221
+/- 1,184
Long-term Liabilities
Long term Debt 468
Long-term Liabilities  (as reported)468
Long-term Liabilities  (calculated)468
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)2,776
Total Stockholder Equity (calculated)0
+/- 2,776
Other
Capital Stock43,632
Common Stock Shares Outstanding 11,931
Net Invested Capital 3,245
Net Working Capital 795



5.2. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302010-06-302002-06-302001-06-302000-06-301999-06-30
> Total Assets 
281,417
289,365
325,409
50,204
1,821
16,733
10,259
9,579
5,935
9,165
4,983
2,542
3,564
8,510
2,555
714
5,649
5,6497142,5558,5103,5642,5424,9839,1655,9359,57910,25916,7331,82150,204325,409289,365281,417
   > Total Current Assets 
59,160
61,816
78,944
33,991
0
16,095
7,089
7,128
3,503
8,261
4,313
2,385
3,484
6,727
787
714
3,200
3,2007147876,7273,4842,3854,3138,2613,5037,1287,08916,095033,99178,94461,81659,160
       Cash And Cash Equivalents 
42,577
39,104
31,674
33,483
0
14,175
2,507
3,013
529
4,135
1,092
255
982
3,793
95
303
2,865
2,865303953,7939822551,0924,1355293,0132,50714,175033,48331,67439,10442,577
       Short-term Investments 
0
0
0
0
0
123
278
0
0
0
0
596
570
570
69
0
0
0069570570596000027812300000
       Net Receivables 
4,200
5,495
9,909
378
533
1,522
230
67
126
1,317
896
647
1,896
2,910
558
383
257
2573835582,9101,8966478961,317126672301,5225333789,9095,4954,200
       Inventory 
10,096
15,945
35,240
0
26
192
206
99
30
22
15
9
12
0
40
0
0
004001291522309920619226035,24015,94510,096
   > Long-term Assets 
0
0
0
0
0
638
3,170
2,451
2,432
904
670
157
80
1,784
1,767
1
2,449
2,44911,7671,784801576709042,4322,4513,17063800000
       Property Plant Equipment 
184,231
188,138
209,953
1,872
72
589
1,362
892
802
610
417
153
80
34
17
1
0
011734801534176108028921,362589721,872209,953188,138184,231
       Long Term Investments 
1,656
1,728
6,136
12,525
0
0
0
0
0
78
41
4
0
0
1,750
0
0
001,75000441780000012,5256,1361,7281,656
       Intangible Assets 
0
0
0
0
0
49
30
26
11
6
2
0
0
0
0
0
2,449
2,44900000261126304900000
       Long-term Assets Other 
0
0
0
0
0
0
1,236
1,533
1,619
210
210
157
-1,225
-1,750
0
0
0
000-1,750-1,2251572102101,6191,5331,236000000
> Total Liabilities 
150,858
128,271
129,200
9,666
450
1,029
1,951
1,307
1,150
1,065
2,061
8,928
3,695
4,365
1,480
2,529
2,873
2,8732,5291,4804,3653,6958,9282,0611,0651,1501,3071,9511,0294509,666129,200128,271150,858
   > Total Current Liabilities 
51,405
47,176
63,048
9,544
450
1,029
1,698
1,260
1,006
876
1,819
8,753
3,633
1,297
1,477
2,529
2,405
2,4052,5291,4771,2973,6338,7531,8198761,0061,2601,6981,0294509,54463,04847,17651,405
       Short-term Debt 
121,506
41,764
29,528
0
0
0
489
253
0
393
1,000
3,780
1,105
5
1,006
1,947
0
01,9471,00651,1053,7801,000393025348900029,52841,764121,506
       Short Long Term Debt 
121,506
41,764
29,528
0
0
0
742
253
0
0
1,000
3,780
1,100
0
1,000
1,947
0
01,9471,00001,1003,7801,0000025374200029,52841,764121,506
       Accounts payable 
10,265
6,568
0
0
284
934
435
453
539
350
372
1,056
556
872
158
501
1,221
1,2215011588725561,056372350539453435934284006,56810,265
       Other Current Liabilities 
8,348
23,826
42,178
2,798
166
95
654
438
466
115
446
7,344
1,440
419
313
81
0
0813134191,4407,344446115466438654951662,79842,17823,8268,348
   > Long-term Liabilities 
0
0
0
0
0
0
253
48
144
189
243
175
63
3,068
3
0
468
468033,0686317524318914448253000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
14
9
3
0
0
003914000000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
19
14
8
0
0
0081419000000000000
       Deferred Long Term Liability 
0
1,327
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001,3270
> Total Stockholder Equity
127,536
155,431
182,737
39,634
1,371
15,704
8,308
8,272
4,785
8,100
2,922
-6,386
-131
4,145
1,075
-1,815
2,776
2,776-1,8151,0754,145-131-6,3862,9228,1004,7858,2728,30815,7041,37139,634182,737155,431127,536
   Common Stock
87,576
83,670
82,034
30,762
2,490
24,978
24,909
31,077
31,077
31,077
31,077
31,077
38,156
38,259
38,619
38,619
0
038,61938,61938,25938,15631,07731,07731,07731,07731,07724,90924,9782,49030,76282,03483,67087,576
   Retained Earnings 
40,339
67,756
83,872
8,457
0
-10,010
-18,792
-25,296
-27,917
-24,630
-29,775
-37,875
-38,718
-34,649
-38,951
-42,277
-42,747
-42,747-42,277-38,951-34,649-38,718-37,875-29,775-24,630-27,917-25,296-18,792-10,01008,45783,87267,75640,339
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
-379
4,005
16,831
415
0
0
2,192
2,491
1,625
1,653
1,619
412
2,229
0
1,407
1,843
0
01,8431,40702,2294121,6191,6531,6252,4912,1920041516,8314,005-379



5.3. Balance Sheets

Currency in AUD. All numbers in thousands.




5.4. Cash Flows

Currency in AUD. All numbers in thousands.




5.5. Income Statements

Currency in AUD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1
Cost of Revenue-0
Gross Profit11
 
Operating Income (+$)
Gross Profit1
Operating Expense-0
Operating Income-1,8341
 
Operating Expense (+$)
Research Development211
Selling General Administrative1,165
Selling And Marketing Expenses0
Operating Expense01,376
 
Net Interest Income (+$)
Interest Income0
Interest Expense-271
Other Finance Cost-0
Net Interest Income-271
 
Pretax Income (+$)
Operating Income-1,834
Net Interest Income-271
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,256-1,684
EBIT - interestExpense = -271
-2,256
-1,985
Interest Expense271
Earnings Before Interest and Taxes (EBIT)0-1,985
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-2,256
Tax Provision-0
Net Income From Continuing Ops-2,256-2,256
Net Income-2,256
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-150271
 

Technical Analysis of Cambium Bio Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cambium Bio Limited. The general trend of Cambium Bio Limited is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cambium Bio Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cambium Bio Limited.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.6 < 0.6 < 0.6.

The bearish price targets are: 0.6 > 0.6 > 0.6.

Tweet this
Cambium Bio Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cambium Bio Limited. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cambium Bio Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cambium Bio Limited. The current macd is 0.03834699.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cambium Bio Limited price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Cambium Bio Limited. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Cambium Bio Limited price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Cambium Bio Limited Daily Moving Average Convergence/Divergence (MACD) ChartCambium Bio Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cambium Bio Limited. The current adx is 36.86.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Cambium Bio Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Cambium Bio Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cambium Bio Limited. The current sar is 0.44870972.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Cambium Bio Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cambium Bio Limited. The current rsi is 90.04. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Cambium Bio Limited Daily Relative Strength Index (RSI) ChartCambium Bio Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cambium Bio Limited. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cambium Bio Limited price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Cambium Bio Limited Daily Stochastic Oscillator ChartCambium Bio Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cambium Bio Limited. The current cci is 206.60.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Cambium Bio Limited Daily Commodity Channel Index (CCI) ChartCambium Bio Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cambium Bio Limited. The current cmo is 91.46.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Cambium Bio Limited Daily Chande Momentum Oscillator (CMO) ChartCambium Bio Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cambium Bio Limited. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Cambium Bio Limited Daily Williams %R ChartCambium Bio Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cambium Bio Limited.

Cambium Bio Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cambium Bio Limited. The current atr is 0.01439325.

Cambium Bio Limited Daily Average True Range (ATR) ChartCambium Bio Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cambium Bio Limited. The current obv is -50,249.

Cambium Bio Limited Daily On-Balance Volume (OBV) ChartCambium Bio Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cambium Bio Limited. The current mfi is 99.21.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Cambium Bio Limited Daily Money Flow Index (MFI) ChartCambium Bio Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cambium Bio Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-31MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-14MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-30MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-17MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Cambium Bio Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cambium Bio Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5090.038
Ma 20Greater thanMa 500.456
Ma 50Greater thanMa 1000.427
Ma 100Greater thanMa 2000.397
OpenGreater thanClose0.595
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cambium Bio Limited with someone you think should read this too:
  • Are you bullish or bearish on Cambium Bio Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cambium Bio Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cambium Bio Limited

I send you an email if I find something interesting about Cambium Bio Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Cambium Bio Limited.

Receive notifications about Cambium Bio Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.